Pressmeddelanden

REG
Eevia revises date for release of Interim report Q3-2024 Eevia Health Plc ("Eevia" or "The Company") will publish its Interim report for the third quarter on November 29 due to the onboarding of a new Board and one large unforeseen urg...
REG
Communique from the EXTRAORDINARY General Meeting OF SHAREHOLDERS in Eevia Health Plc The Extraordinary General Meeting of Shareholders of Eevia Health Plc, corp. Reg. No 2825194-4 (the "Company") was held on November 4, 2024, in Seinäjoki, Finland, whereby the sh...
Eevia goes neck and neck with the market leader in a new whitepaper Eevia Health Plc ("Eevia" or "The Company") has published a follow-up whitepaper of its research article published on May 2. The whitepaper showcases one of its hero products, Fe...
REG
UPDATE: Dr. Diane Clayton suggested as new Board member in Eevia Health A press release on October 7 (Correction on November 14) notified the shareholders of Eevia Health Plc ("Eevia" or "The Company") of an Extraordinary General Meeting to be held o...
Eevia Health Plc receives a 587 KSEK (51 KEUR) sales order for a Bilberry extract product Eevia Health Plc ("Eevia" or "The Company") has received a 51 KEUR sales order from a European nutraceutical brand owner.
REG MAR
CORRECTION: Eevia Health enters negotiations for a significant sales contract The correction is related to a press release on 12.01.2024 where Eevia Health Plc ("Eevia" or the "Company") announced it had entered negotiations with a European food manufactur...
Visa fler pressmeddelanden

Rapporter

Video

Finansiell kalender

Delårsrapport Q3 2024 Delårsrapport
Bokslutskommuniké 2024 Bokslutskommuniké
Delårsrapport Q1 2025 Delårsrapport
Delårsrapport Q2 2025 Delårsrapport

Om Eevia Health

Eevia Health targets health problems with bioactive extracts from plant material. The human body has an incredible ability to restore good health. However, sometimes the body needs active support. Our mission is to support good health and well-being with plant extracts which have scientifically documented health benefits. Eevia Health manufactures and markets organic ingredients from abundant plant material in the Arctic. Our products are targeted against low-grade inflammation, problems in eye and brain health, and metabolic effects. We collaborate with scientists in Finland and abroad to scientifically substantiate the positive effects of ingredients and also to document the safety of use.

Webbplats
eeviahealth.com/investors

Handelsinformation

Kurs ()
Förändring ()
Marknad Spotlight stock market Kortnamn EEVIA ISIN-kod FI4000496658

IR-Kontakt

Stein Ulve IR-kontakt [email protected]